Zika virus (ZIKV), a neurotropic single-stranded RNA flavivirus, remains an important cause
of congenital infection, fetal microcephaly, and Guillain-Barré syndrome in populations …

Approximately 100–400 million people from more than 100 countries in the tropical and
subtropical world are affected by dengue infections. Recent scientific breakthroughs have …

While progress has been made in characterizing humoral immunity to Zika virus (ZIKV) in
humans, little is known regarding the corresponding T cell responses to ZIKV. Here, we …

Zika virus (ZIKV) and dengue virus (DENV) are antigenically related flaviviruses that share
cross-reactivity in antibody and T cell responses, and co-circulate in increasing numbers of …

Dengue is a mosquito-borne disease which causes significant public health concerns in
tropical and subtropical countries. Dengue virus (DENV) has evolved various strategies to …

Dengue virus (DENV) infection is one of the major public health concerns around the globe,
especially in the tropical regions of the world that contribute to 75% percent of dengue …

Protective adaptive immunity to Zika virus (ZIKV) has been mainly attributed to cytotoxic
CD8+ T cells and neutralizing antibodies, while the participation of CD4+ T cells in …

Abstract Background Various Zika virus (ZIKV) vaccine candidates are currently in
development. Nevertheless, unique challenges in clinical development and regulatory …

Background Dengue is a major public health problem worldwide. Assessment of adaptive
immunity is important to understanding immunopathology and to define correlates of …

Arboviral infections such as Chikungunya (CHIKV), Dengue (DENV) and Zika (ZIKV) are a
major disease burden in tropical and sub-tropical countries, and there are no effective …